(International Association for the Study of Lung Cancer) The combined use of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) identified non-small cell lung cancer (NSCLC) patients with rare or novel anaplastic lymphoma kinase (ALK) gene rearrangements, not otherwise identified by FISH alone, that showed response to crizotinib treatment.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2cDcN8l
No comments:
Post a Comment